Windlas Biotech Share Price
1130.00+2.90 (+0.26%)
+15.33% past 1 Year
Windlas Biotech Limited provides pharmaceutical development services, large-scale manufacturing services and authentic yet affordable products to its customers and consumers around the world. The company is amongst the top five
Corporate filings & documents
Announcements
Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
2 days agoIntimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
2 days agoQ1 FY27 Earnings Conference Call Transcript enclosed.
2 weeks agoQ1 FY27 Earnings Conference Call Transcript enclosed.
2 weeks agoAudio Recording Q1 conference call
3 weeks agoAudio Recording Q1 conference call
3 weeks agoPress release titled Windlas Biotech Limited Reports its Q1 FY27 Financial Results
3 weeks agoPress release titled Windlas Biotech Limited Reports its Q1 FY27 Financial Results
3 weeks agoInvestor Presentation - Q1 FY27 enclosed
3 weeks agoInvestor Presentation - Q1 FY27 enclosed
3 weeks agoapproval of the Unaudited Standalone Financial Results for the Quarter ended June 30 2026.
3 weeks agoapproval of the Unaudited Standalone Financial Results for the Quarter ended June 30 2026.
3 weeks agoapproval of the Unaudited Standalone Financial Results for the Quarter ended June 30 2026.
3 weeks agoapproval of the Unaudited Standalone Financial Results for the Quarter ended June 30 2026.
3 weeks agoSchedule of Conference Call to discuss financial performance for quarter ended June 30 2026
4 weeks agoSchedule of Conference Call to discuss financial performance for quarter ended June 30 2026
4 weeks agoSchedule of Conference Call to discuss financial performance for quarter ended June 30 2026
1 month agoSchedule of Conference Call to discuss financial performance for quarter ended June 30 2026
1 month agoWindlas Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve Notice is hereby given that pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 a meeting of the Board of Directors of the Company is scheduled to be held on Monday August 10 2026 inter alia to consider and approve the un-audited standalone financial results for the quarter ended June 30 2026.
1 month agoWindlas Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve Notice is hereby given that pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 a meeting of the Board of Directors of the Company is scheduled to be held on Monday August 10 2026 inter alia to consider and approve the un-audited standalone financial results for the quarter ended June 30 2026.
1 month agoSubmission of Combined Voting Results and Scrutinizers Report under Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) of the 25th Annual General Meeting held on July 23 2026
1 month agoSubmission of Combined Voting Results and Scrutinizers Report under Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) of the 25th Annual General Meeting held on July 23 2026
1 month agoSubmission of Combined Voting Results and Scrutinizers Report under Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) of the 25th Annual General Meeting held on July 23 2026
1 month agoSubmission of Combined Voting Results and Scrutinizers Report under Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) of the 25th Annual General Meeting held on July 23 2026
1 month agoProceedings of 25th Annual General Meeting of the Company held on July 23 2026 pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
1 month agoProceedings of 25th Annual General Meeting of the Company held on July 23 2026 pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
1 month agoCertificate under Regulation 74 (5) of the SEBl (Depositories and Participants) Regulations 2018 for the Quarter ended June 30 2026
1 month agoCertificate under Regulation 74 (5) of the SEBl (Depositories and Participants) Regulations 2018 for the Quarter ended June 30 2026
1 month agoIntimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
1 month agoIntimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
1 month agoNewspaper Advertisement of completion of despatch of the Notice of 25th Annual General Meeting and Annual Report for the financial year 2025-2026
2 months agoNewspaper Advertisement of completion of despatch of the Notice of 25th Annual General Meeting and Annual Report for the financial year 2025-2026
2 months agoIntimation of record date/ cut-off date for the 25th AGM and evoting
2 months agoIntimation of record date/ cut-off date for the 25th AGM and evoting
2 months agoAnnual Report for FY26
2 months agoAnnual Report for FY26
2 months agoNotice of 25th AGM to be held on July 23 2026
2 months agoNotice of 25th AGM to be held on July 23 2026
2 months agoNotice of 25th AGM
2 months agoNotice of 25th AGM
2 months agoIntimation of cut-off date for evoting and dividend
2 months agoIntimation of cut-off date for evoting and dividend
2 months agoNewspaper Advertisement of 25th Annual General Meeting
2 months agoNewspaper Advertisement of 25th Annual General Meeting
2 months agoIntimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015- Credit Rating
2 months agoIntimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015- Credit Rating
2 months agoIntimation of Schedule of Analyst/Institutional Investor Meetings
2 months agoIntimation of Schedule of Analyst/Institutional Investor Meetings
2 months agoIntimation of Closure of Trading Window
2 months agoIntimation of Closure of Trading Window
2 months agoAnnual reports
Concalls & investor presentations
Aug 2026
ConcallPresentation
Aug 2026
ConcallPresentation
May 2026
ConcallPresentation
May 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Nov 2025
ConcallPresentation
Aug 2025
ConcallPresentation
Aug 2025
ConcallPresentation
May 2025
ConcallPresentation
May 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Nov 2024
ConcallPresentation
Nov 2024
ConcallPresentation
Aug 2024
ConcallPresentation
Aug 2024
ConcallPresentation
May 2024
ConcallPresentation
May 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Nov 2023
ConcallPresentation
Nov 2023
ConcallPresentation
Aug 2023
ConcallPresentation
Aug 2023
ConcallPresentation
May 2023
ConcallPresentation
May 2023
ConcallPresentation
Feb 2023
ConcallPresentation
Feb 2023
ConcallPresentation
Nov 2022
ConcallPresentation
Nov 2022
ConcallPresentation
Aug 2022
ConcallPresentation
Aug 2022
ConcallPresentation
May 2022
Feb 2022
ConcallPresentation
Feb 2022
ConcallPresentation
Nov 2021
Sept 2021
ConcallPresentation
Sept 2021
ConcallPresentation
Corporate Actions
Date
Type
Details
2026-07-16
Dividend
6.3
2025-07-21
Dividend
5.8
2024-09-17
Dividend
5.5
2023-09-05
Dividend
4.0
2022-09-09
Dividend
3.5
Company details
Registered office
40 / 1 Mohabewala Industrial Area NULL Dehradun Uttarakhand PIN: 248110 Tel No: 0135-6608000-30 Fax No: 0135-6608199 Email: [email protected] Internet: www.windlasbiotech.com
Registrars
C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Ananta Narayan Panda, Company Secretary & Compliance Officer
Ashok Kumar Windlass, Whole Time Director
Hitesh Windlass, Managing Director
Manoj Kumar Windlass, Joint Managing Director
Pawan Kumar Sharma, Executive Director
Prachi Jain Windlass, Non Executive Director
Vivek Dhariwal, Chairman
Gaurav Gulati, Non Executive Independent Director
Tarashree Singhal, Non Executive Independent Director
Details
BSE 543329
NSE WINDLAS
ISIN INE0H5O01029